Naltrexone/bupropion

Grey

Brand Name(s):Mysimba

Indication:Weight management

Rationale:1

Considered:Aug-17

Review Date:Sep-24

Comments:
Drug safety update Naltrexone/bupropion (Mysimba?): risk of adverse reactions that could affect ability to drive
Advise patients that naltrexone/bupropion has been associated with adverse reactions such as dizziness or somnolence, which can affect ability to drive, operate machinery, or perform dangerous tasks. ………………………… Non-formulary